In this podcast, Motley Fool co-founder David Gardner is joined by George Khalaf, executive director of the Fool Community ...
1d
Salarius Pharmaceuticals to Collaborate with Texas Biomedical Research Institute on Avian Flu Study
Salarius subsidiary Decoy Therapeutics’ influenza fusion inhibitors, designed using its proprietary IMP3ACT™ platform, show ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback